Results of a new study have scientists questioning just how much protection the monkeypox vaccine actually offers. Scientists in the Netherlands found two shots of the [monkeypox] vaccine being used in the U.S. and other parts of the world yield very low levels of neutralizing antibodies against the monkeypox virus. This has them concerned people who are vaccinated may have a false sense of security against exposure. In response to the study findings, Dr. Inger Damon of the CDC said, “Foundational to all of this will be to understand progression of disease and the immune response to disease with the different routes of infection that with the different routes of infection that we believe we are seeing.”
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
5 Responses
Hmmmmm… when have we heard this nonsense before?
The real question is, “How much money can we make from another ineffective vaccine?” That’s all they really care about.
It’s much more than the money. They do like for the test monkeys (pun intended) to actually contract the disease they claim to want to prevent. If the test monkey doesn’t die, then pharma may have a customer for an extended period of time or, even for life. Therefore, it’s a much bigger payoff if the test monkey doesn’t initially die but dies more slowly. Either way, the end result is what the big boys at the WHO, CDC, etc. really want.
You can’t measure effectiveness by antibody level.🛑
They shouldn’t be more concerned about the danger of a toxic live vaccine that causes blisters that are contagious.
To stop money pox. Shower together before intimate touch therapy.
And wash sheets and towels between customers.
You can’t measure vaccine effectiveness by antibody level.
If you want to stop monkey pox take a shower together before intimate touch therapy.
Also we didn’t have money pox before COVID shots.
Is money pox a result from COVID shots 🤔 ?